Quantcast

Latest Forward-looking statement Stories

2014-07-30 08:34:05

LAS VEGAS, July 30, 2014 /PRNewswire/ -- DigiPath, Inc. (OTCBB and OTCQB: DIGP), a digital pathology solution provider that is expanding into the cannabis testing and education markets, announced today that has been no material development in its business and affairs not previously disclosed or, to its knowledge, any other reason to account for the recent unusual market action. http://photos.prnewswire.com/prnvar/20140605/94753 "We have noticed unusual price and volume increases for...

2014-07-30 08:33:40

LONDON, July 30, 2014 /PRNewswire/ -- Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical company developing addiction treatments based on its expertise in opioid antagonists, announced today that it has received a funding commitment from a prominent international research and development foundation. The foundation has a focus on promoting innovative research-based initiatives, including those addressing health issues. Lightlake has been developing a nasal...

2014-07-30 08:33:34

JUPITER, Fla., July 30, 2014 /PRNewswire/ -- Dyadic International, Inc. ("Dyadic") (OTCQX: DYAI), is a global biotechnology company whose patented and proprietary technologies are used to discover, develop, manufacture and sell enzymes and other proteins for the bioenergy, bio-based chemical, biopharmaceutical and industrial enzyme industries, announced today the appointment of Thomas "Tom" Dubinski as Vice President and Chief Financial Officer. Tom will be responsible for leading the...

2014-07-30 08:33:18

DUBLIN, July 30, 2014 /PRNewswire/ -- Perrigo Company (NYSE: PRGO;TASE) announced that it has filed with the U.S. Food and Drug Administration (FDA) an Abbreviated New Drug Application for desoximetasone topical spray 0.25% and that it has notified Taro Pharmaceuticals U.S.A., Inc., the owner of the Reference Listed Drug of its filing. http://photos.prnewswire.com/prnvar/20120301/DE62255LOGO On July 28, 2014, Taro filed suit against Perrigo in the United States District Court for...

2014-07-30 08:32:50

SAN DIEGO, July 30, 2014 /PRNewswire/ -- Orexigen Therapeutics, Inc. (Nasdaq: OREX) today announced it has received the Day 180 List of Outstanding Issues (LOI) from the European Medicines Agency's Committee for Medicinal Products for Human Use (CHMP) for the NB32 Marketing Authorization Application (MAA). NB32 (naltrexone sustained release (SR) / bupropion SR) is an investigational drug candidate being evaluated for weight loss. The key questions of the earlier Day 120 time point...

2014-07-30 08:28:39

SALT LAKE CITY, July 30, 2014 /PRNewswire/ -- CMK Gaming International, Inc. (OTC PINK: "CMKI") announced that it expects to open its first U.S. pachinko parlor, which will be located in Salt Lake City, Utah. This year, the Company purchased its Japanese wholly-owned subsidiary corporation that owns and operates three pachinko parlors in Japan. The majority of its subsidiaries' income is derived from its three pachinko parlors located throughout Japan. The Company believes that its...

2014-07-30 08:24:55

HOUSTON, July 30, 2014 /PRNewswire/ -- Flotek Industries, Inc. ("Flotek" or the "Company") (NYSE: FTK) will host a conference call on Thursday, August 7, 2014 at 7:30 a.m. Central Standard Time to discuss its financial and operating results for the three-months ended June 30, 2014. Flotek intends to provide dial-in information through a press release on August 6, 2014. Flotek plans to file its 10-Q after the market close on Wednesday, August 6, 2014. In addition, the Company will...

2014-07-29 20:24:49

BROOMFIELD, Colo., July 29, 2014 /PRNewswire/ -- Level 3 Communications, Inc. (NYSE: LVLT) today announced that Level 3 Escrow II, Inc., its indirect, wholly owned subsidiary, has agreed to sell $1 billion aggregate principal amount of its 5.375% Senior Notes due 2022 in a private offering to "qualified institutional buyers," as defined in Rule 144A under the Securities Act of 1933, as amended, and non-U.S. persons outside the United States under Regulation S under the Securities Act...

2014-07-29 20:22:30

OKLAHOMA CITY, July 29, 2014 /PRNewswire/ -- Compressco Partners, L.P. ("Compressco") (NASDAQ: GSJK) announced today that it, and its wholly owned subsidiary Compressco Finance Corp., have priced their previously announced private offering of $350 million in aggregate principal amount of senior notes due 2022 at a price to investors of 98.508% and with a coupon of 7.25% per annum. Compressco expects the offering of the notes to close on August 4, 2014, subject to the satisfaction of...

2014-07-29 20:21:54

HOUSTON, July 29, 2014 /PRNewswire/ -- Westlake Chemical Partners LP (the "Partnership"), a Westlake company, today announced the pricing of its initial public offering of 11,250,000 common units representing limited partner interests in the Partnership at $24.00 per common unit. The Partnership has also granted the underwriters a 30-day option to purchase up to an additional 1,687,500 common units. The common units are expected to begin trading on the New York Stock Exchange (NYSE)...


Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related